This session will equip viewers with practical tools to recognize, evaluate, and manage mild cognitive impairment (MCI) in everyday practice. Through real-world cases, participants will review diagnostic criteria, workflow-friendly cognitive screening strategies, documentation best practices, and the critical role of caregiver input. The program will also explore emerging Alzheimer’s research, including disease-modifying therapies, anti-amyloid monoclonal antibodies, biomarker advances, and the implications of treatment eligibility.